拓宽适应证:创伤与非创伤患者静脉-静脉体外膜氧合结局的描述性与比较性深度分析
这项单中心回顾性队列研究纳入8年间516例接受VV ECMO的患者(非创伤438例、创伤78例),创伤定义为初次创伤住院期间置管。创伤患者更年轻(中位29岁 vs 41岁)、置管更早(8小时 vs 120小时)、置管前乳酸更高(4.2 mmol/L vs 2.3 mmol/L)、SOFA评分更高(13 vs 11)、SAPS II更高(63 vs 48),ECMO运行时间更短(216小时 vs 372小时),出血并发症无差异。两组出院存活率相似(69% vs 71%,p=0.81)。作者认为VV ECMO是创伤患者因急性肺与胸部损伤所致难治性低氧血症、呼吸性酸中毒和稳定化时的有用治疗方式。
要点
- 创伤患者VV ECMO出院存活率与非创伤患者相似(69% vs 71%,p=0.81),尽管前者病情更重。
- 创伤患者置管前乳酸更高(4.2 mmol/L vs 2.3 mmol/L,p<0.001)、SOFA更高(13 vs 11,p=0.001)、SAPS II更高(63 vs 48,p<0.001)。
- 创伤患者置管更早(8小时 vs 120小时,p<0.001),ECMO运行时间更短(216小时 vs 372小时,p<0.001)。
- 两组出血并发症无差异。
- 作者认为VV ECMO是创伤患者因急性肺与胸部损伤所致难治性低氧血症、呼吸性酸中毒和稳定化时的有用治疗方式。
适用人群与场景
- 8年期间单中心所有接受VV ECMO的创伤与非创伤患者;创伤患者定义为初次创伤住院期间置管。
处置流程与药物剂量
- 置管决策由两名重症医师与一名创伤外科医师多学科讨论后做出。
研究设计与关键结果
- 单中心回顾性队列研究,共516例接受VV ECMO患者(非创伤438例、创伤78例)。
- 创伤患者中位年龄29岁、男性81%;非创伤患者中位年龄41岁、男性64%。
- 创伤组ECMO运行时间更短(216小时 vs 372小时,p<0.001),置管更早(8小时 vs 120小时,p<0.001)。
- 创伤组置管前乳酸更高(4.2 mmol/L vs 2.3 mmol/L,p<0.001)、SOFA评分更高(13 vs 11,p=0.001)、SAPS II更高(63 vs 48,p<0.001)。
- 两组出血并发症无差异。
- 出院存活率创伤组与非创伤组相似(69% vs 71%,p=0.81)。
证据类型、等级与局限
- 证据类型:单中心回顾性队列研究;证据等级:治疗/护理管理 Level IV。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,VV ECMO是创伤患者因急性肺与胸部损伤所致难治性低氧血症、呼吸性酸中毒和稳定化时的有用治疗方式。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Venovenous extracorporeal membrane oxygenation (VV ECMO) has been used for medical etiologies of acute respiratory distress syndrome refractory to conventional management. More recently, VV ECMO has been used to stabilize trauma patients with acute lung injury. We hypothesize that patients with traumatic injuries requiring VV ECMO have similar survival outcomes and describe the characteristics between the two populations.
METHODS: This single-center, retrospective cohort study included all trauma and nontrauma patients in an 8-year period who were placed on VV ECMO. Cannulation decisions were made via multidisciplinary discussions between two intensivists and a trauma surgeon. Data were analyzed with descriptive statistics and regression analysis. After testing for normality, significance was defined as a p < 0.05.
RESULTS: A total of 516 patients were identified (438 nontrauma and 78 trauma VV ECMO patients). The trauma patient, defined as undergoing cannulation during initial trauma admission, had a median age of 29 years with 81% of patients being male, while the nontrauma patient had a median age of 41 years with 64% being males. Trauma VV ECMO patients had shorter ECMO courses (216 hours vs. 372 hours, p < 0.001), earlier cannulation (8 hours vs. 120 hours, p < 0.001), higher lactic acid levels precannulation (4.2 mmol/L vs. 2.3 mmol/L, p < 0.001), higher Sequential Organ Failure Assessment scores (13 vs. 11, p = 0.001), and higher Simplified Acute Physiology Scores II (63 vs. 48, p < 0.001). There was no difference in bleeding complications. Survival to discharge rates were similar between trauma and nontrauma VV ECMO groups (69% vs. 71%, p = 0.81).
CONCLUSION: This study demonstrates that trauma VV ECMO patients have higher markers of severe illness/injury when compared with their nontrauma VV ECMO counterparts yet have similar survival rates and shorter ECMO runs. Venovenous extracorporeal membrane oxygenation in trauma patients is a useful treatment modality for refractory hypoxemia, respiratory acidosis, and stabilization because of acute lung and thoracic injury.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level IV.
参考来源
- Spivak H, Rao A, Haase D, et al. Broadening indications: A descriptive and comparative in-depth analysis of venovenous extracorporeal membrane oxygenation outcomes in trauma and nontrauma patients. J Trauma Acute Care Surg. 2024. PMID: 39560952. doi:10.1097/TA.0000000000004485
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。